Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice

Journal of Clinical Investigation

Volumn 93, Issue 4, 1994, Pages 1403-1410

  Van Vlijmen, Bart J M ^a   Van Den Maagdenberg, Arn M J M ^b   Gijbels, Marion J J ^a   Van Der Boom, Hans ^a   HogenEsch, Harm ^a,c   Frants, Rune R ^b   Hofker, Marten H ^b   Havekes, Louis M ^a  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c PURDUE UNIVERSITY   (United States)

Author keywords

atherosclerotic plaques; cholesterol rich diets; familial dysbetalipoproteinemia; hypercholesterolemia; hypertriglyceridemia

Indexed keywords

APOLIPOPROTEIN E3; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CALCIFICATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; DIETARY INTAKE; DNA SEQUENCE; FIBROSIS; HYPERLIPOPROTEINEMIA; HYPERLIPOPROTEINEMIA TYPE 3; LIPID ANALYSIS; LIPID COMPOSITION; LIPID DIET; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0028215636     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI117117     Document Type: Article

References (30)

1. Havel, R. J., Y.-S. Chao. E. Windier, L. Kotite, and L. S. S. Guo. 1980. Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia. Proc. Natl. Acad. Sci. USA. 77:4349-4353.
2. Sherill, B. C., T. L. Innerarity, and R. W. Mahley. 1980. Rapid hepatic clearance of the canine lipoproteins containing only the E apoprotein by a high affinity receptor. J. Biol. Chem. 255:1804-1807.
3. Mahley, R. W. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science (Wash. DC). 240:622-630.
4. Mahley, R. W., T. L. Innerarity, S. C. Rail, Jr., K. H. Weisgraber, and J. M. Taylor. 1990. Apolipoprotein E: genetic variants provide insight into its structure and function. Curr. Opin. Lipid. 1:87-95.
5. Mahley, R. W., and S. C. Rail, Jr. 1989. Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal metabolism. In The Metabolic Basis of Inherited Disease. C. R. Scriver, A. L. Beaudel, W. S. Sly, and D. Valle, editors. McGraw-Hill Inc., New York. 1195-1213.
6. de Knijff, P., A. M. J. M. van den Maagdenberg, A. F. H. Stalenhoef, J. A. Gevers Leuven, P. N. M. Demacker, L. P. Kuyt, R. R. Frants, and L. M. Havekes. 1991. Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree. J. Clin. Invest. 88:643-655.
7. van den Maagdenberg, A. M. J. M., M. H. Hofker, P. J. A. Krimpenfort, I. H. de Bruijn, B. van Vlijmen, H. van der Boom, L. M. Havekes, and R. R. Frants. 1993. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J. Biol. Chem. 268:10540-10545.
8. Simonet, W. S., N. Bucay, S. J. Lauer, D, O. Wirak, M. E. Stevens, K. H. Weisgraber, R. E. Pitas, and J. M. Taylor. 1990. In the absence of a downstream element, the apolipoprotein E gene is expressed at high levels in kidneys of transgenic mice. J. Biol. Chem. 265:10809-10812.
9. Simonet, W. S., N. Bucay, R. E. Pitas, S. J. Lauer, and J. M. Taylor. 1991. Multiple tissue-specific elements control the apolipoprotein E/C-1 gene locus in transgenic mice. J. Biol. Chem. 266:8651-8654.
10. Nishina, P. M., J. Verstuyft, and B. Paigen. 1990. Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J. Lipid Res 31:859-869.
11. Lopez-Virella, M. F., P. Stone, S. Ellis, and J. A. Colwell. 1977. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin. Chem. 23:882-884.
12. Paigen, B., P. A. Holmes, D. Mitchell, and R. A. Williams. 1987. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68:231-240.
13. Mahley, R. W., K. H. Weisgraber, M. M. Hussain, B. Greenman, M. Fisher, T. Vogel, and M. Gorecki. 1989 Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits. J Clin. Invest. 83:2125-2130.
14. Shimano, H., N. Yamada, M. Katsuki, M. Shimada, T. Gotoda, K. Harada, T. Murase, C. Fukazawa, F. Takaku, and Y. Yakazi. 1992. Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia. Proc. Natl Acad. Sci. USA 89:1750-1754.
15. Shimano, H., N. Yamada, M. Katsuki, K. Yamamoto, T. Gotoda, K. Harada, M. Shimada, and Y. Yazaki. 1992. Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B. J. Clin. Invest. 90:2084-2091.
16. Grundy, S. M., and M. A. Denke. 1990. Dietary influences on serum lipids and lipoproteins. J. Lipid Res 31:1149-1172.
17. Witztum, J. L., and G. Schonfeld. 1978. Carbohydrate diet induced changes in very low density lipoprotein composition and structure. Diabetes. 27:1215-1229.
18. Lusis, A. J., B. A. Taylor, D. Quon, S. Zollman, and R. C. LeBoeuf. 1987. Genetic factors controlling structure and expression of apolipoproteins B and E in mice. J. Biol. Chem 262:7594-7604.
19. LeBoeuf, R., D. Puppione, V. Schumaker, and A. Lusis. 1983. Genetic control of lipid transport in mice. I. Structural properties and polymorphisms of plasma lipoproteins. J. Biol. Chem. 258:5063-5070.
20. Paigen, B., A. Morrow, C. Brandon, D. Mitchell, and P. Holms. 1985. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 57:65-73.
21. Agellon, L. B., A. Walsh, T. Hayek, P. Moulin, X. C. Jiang, S. A. Shelanski, and A. R. Tall. 1991. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J. Biol. Chem. 266:10796-10801.
22. Jiang, X. C., L. B. Agellon, A. Walsh, J. L. Breslow, and A. Tall. 1992. Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences. J. Clin. Invest. 90:1290-1295.
23. Munro, J. M., and R. S. Cotran. 1988. Biology of disease. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab. Invest. 58:249-261.
24. Ishida, B. Y., and B. Paigen. 1989. Atherosclerosis in the mouse. In Genetic Factors in Atherosclerosis: Approaches and Model Systems. A. J. Lusis and S. R. Sparkes, editors. S. Karger, AG Basel. 189-222.
25. Plump, A. S., J. D. Smith, T. Hayek, K. Aalto-Setälä, A. Walsh, J. G. Verstuyft, E. M. Rubin, and J. L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:343-353.
26. Zhang, S. H., R. L. Reddick, J. A. Piedrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science (Wash. DC). 258:468-471.
27. Piedrahita, J. A., S. H. Zhang, J. R. Hagaman, P. M. Oliver, and N. Maeda. 1992. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 89:4471-4475.
28. Stewart-Phillips, J. L., and J. Lough. 1991. Pathology of atherosclerosis in cholesterol-fed, susceptible mice. Atherosclerosis. 90:211-218.
29. Paigen, B., P. A. Holmes, D. Mitchell, and D. Albee. 1987. Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosteronetreated female mice from strains C57BL/6, BALP/c, and C3H. Atherosclerosis. 64:215-221.
30. Warden, C. H., C. C. Hedrick, J. H. Qiao, L. W. Castellani, and A. J. Lusis. 1993. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science (Wash. DC). 261:469-472.